Search results
Biogen Inc. (NASDAQ:BIIB) Shares Bought by FIL Ltd
ETF DAILY NEWS· 7 days agoFIL Ltd raised its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 936.4% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 656,502 shares of ...
Livelsberger Financial Advisory Invests $26,000 in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 3 days agoLivelsberger Financial Advisory purchased a new position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) during the fourth quarter, according to the company in its most recent disclosure ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Garde Capital Inc.
ETF DAILY NEWS· 6 days agoGarde Capital Inc. lowered its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 60.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm ...
Johnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the...
Morningstar· 24 hours agoJohnson & Johnson (NYSE: JNJ) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of TREMFYA ...
AbbVie (NYSE:ABBV) Shares Up 0%
ETF DAILY NEWS· 6 days agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 0% during mid-day trading on Thursday . The company traded as high as $166.45 and last traded at $166.15. ABBV has been the topic ...
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks· 15 hours agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Imfinzi.
Gerber LLC Makes New $342,000 Investment in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 4 days agoGerber LLC bought a new stake in Amgen Inc. (NASDAQ:AMGN – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission ...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks· 3 days agoFree Report) announced that the FDA has granted approval to its blockbuster drug, Skyrizi to treat adults with moderately to severely active ulcerative colitis (UC) in the ...
Amgen Inc. (NASDAQ:AMGN) Sees Significant Drop in Short Interest
ETF DAILY NEWS· 5 days agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) was the recipient of a large decrease in short interest in May. As of May 31st, there was short interest totalling 9,050,000 shares, a decrease of ...
MONECO Advisors LLC Decreases Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 4 days agoMONECO Advisors LLC trimmed its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 11.2% during the fourth quarter, HoldingsChannel reports. The firm owned 1,741 shares of the medical research ...
